Bharat Biotech seeks full marketing approval from DCGI for Covaxin
NEW DELHI: Bharat Biotech has sought from the Drugs Controller General of India regular market approval for its COVID-19 vaccine...
NEW DELHI: Bharat Biotech has sought from the Drugs Controller General of India regular market approval for its COVID-19 vaccine...
NEW DELHI: Bharat Biotech International Limited (BBIL), on Thursday announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has...
NEW DELHI: Bharat Biotech announced on Thursday that it will donate two lakh doses of its Covid-19 vaccine Covaxin to...
HYDERABAD: Brazil has suspended the clinical studies of Bharat Biotech's COVID-19 vaccine, Covaxin following termination of the company's agreement with...
HYDERABAD: Ocugen Inc., Bharat Biotech's partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to...
HYDERABAD: Ocugen Inc, Bharat Biotech's US and Canada partner for its COVID-19 vaccine Covaxin, said it has chosen Jubilant HollisterStier...
NEW DELHI: The government of India has set the maximum price private hospitals can charge for the three Covid-19 vaccines...
NEW DELHI: In the first of its kind study since the launch of the AstraZeneca's Covishield and Bharat Biotech's Covaxin...
NEW DELHI: Bharat Biotech on Friday said it has dispatched COVID vaccine Covaxin to various states like Gujarat, Assam, Tamil...
NEW DELHI: The National Regulator of India, the Drugs Controller General of India (DCGI), after careful examination, has accepted the...